Immunogenicity of adjuvanted recombinant zoster vaccine in patients with rheumatoid arthritis treated with upadacitinib: 60-week results from a randomised controlled trial substudy

ABSTRACT:

SUBMITTER: Winthrop K 

PROVIDER: S-EPMC12352179 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature